» Articles » PMID: 38321340

Empowering PET: Harnessing Deep Learning for Improved Clinical Insight

Overview
Journal Eur Radiol Exp
Date 2024 Feb 6
PMID 38321340
Authors
Affiliations
Soon will be listed here.
Abstract

This review aims to take a journey into the transformative impact of artificial intelligence (AI) on positron emission tomography (PET) imaging. To this scope, a broad overview of AI applications in the field of nuclear medicine and a thorough exploration of deep learning (DL) implementations in cancer diagnosis and therapy through PET imaging will be presented. We firstly describe the behind-the-scenes use of AI for image generation, including acquisition (event positioning, noise reduction though time-of-flight estimation and scatter correction), reconstruction (data-driven and model-driven approaches), restoration (supervised and unsupervised methods), and motion correction. Thereafter, we outline the integration of AI into clinical practice through the applications to segmentation, detection and classification, quantification, treatment planning, dosimetry, and radiomics/radiogenomics combined to tumour biological characteristics. Thus, this review seeks to showcase the overarching transformation of the field, ultimately leading to tangible improvements in patient treatment and response assessment. Finally, limitations and ethical considerations of the AI application to PET imaging and future directions of multimodal data mining in this discipline will be briefly discussed, including pressing challenges to the adoption of AI in molecular imaging such as the access to and interoperability of huge amount of data as well as the "black-box" problem, contributing to the ongoing dialogue on the transformative potential of AI in nuclear medicine.Relevance statementAI is rapidly revolutionising the world of medicine, including the fields of radiology and nuclear medicine. In the near future, AI will be used to support healthcare professionals. These advances will lead to improvements in diagnosis, in the assessment of response to treatment, in clinical decision making and in patient management.Key points• Applying AI has the potential to enhance the entire PET imaging pipeline.• AI may support several clinical tasks in both PET diagnosis and prognosis.• Interpreting the relationships between imaging and multiomics data will heavily rely on AI.

Citing Articles

A Systematic Review of the Applications of Deep Learning for the Interpretation of Positron Emission Tomography Images of Patients with Lymphoma.

Kanavos T, Birbas E, Zanos T Cancers (Basel). 2025; 17(1.

PMID: 39796698 PMC: 11719749. DOI: 10.3390/cancers17010069.

References
1.
Maebe J, Vandenberghe S . Simulation study on 3D convolutional neural networks for time-of-flight prediction in monolithic PET detectors using digitized waveforms. Phys Med Biol. 2022; 67(12). DOI: 10.1088/1361-6560/ac73d3. View

2.
Schwenck J, Kneilling M, Riksen N, Fougere C, Mulder D, Slart R . A role for artificial intelligence in molecular imaging of infection and inflammation. Eur J Hybrid Imaging. 2022; 6(1):17. PMC: 9433558. DOI: 10.1186/s41824-022-00138-1. View

3.
Hasani N, Paravastu S, Farhadi F, Yousefirizi F, Morris M, Rahmim A . Artificial Intelligence in Lymphoma PET Imaging:: A Scoping Review (Current Trends and Future Directions). PET Clin. 2021; 17(1):145-174. PMC: 8735853. DOI: 10.1016/j.cpet.2021.09.006. View

4.
Kratochwil C, Fendler W, Eiber M, Baum R, Bozkurt M, Czernin J . EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2019; 46(12):2536-2544. DOI: 10.1007/s00259-019-04485-3. View

5.
Visvikis D, Rest C, Jaouen V, Hatt M . Artificial intelligence, machine (deep) learning and radio(geno)mics: definitions and nuclear medicine imaging applications. Eur J Nucl Med Mol Imaging. 2019; 46(13):2630-2637. DOI: 10.1007/s00259-019-04373-w. View